Kiersten Stead

DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California.

X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA.

Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA.

Verdant Robotics, Inc. engages in the provision of autonomous farming services. It transforms profits by digitally mapping the entire farm across time and space. The company was founded by Gabe Sibley and is headquartered in Hayward, CA.

Mycoworks, Inc. engages in producing leather from mycelium materials. The company was founded by Sophia Wang, Philip Ross and Eddie Pavlu and is headquartered in San Jose, CA.

Stemson Therapeutics, LLC is a pre-clinical stage cell therapy company that aims to cure hair loss by using induced pluripotent stem cells to regenerate the critical cells required to grow hair. The company is based in La Jolla, CA, and is passionate about delivering a scientifically based, clinically tested cure for hair loss to the millions of hair loss sufferers who seek help for their hair loss condition. Stemson's breakthrough innovation uses a novel cell engineering process to produce the cell types required to regenerate hair follicles. The company was founded in 2018 by Geoff Hamilton and a team of world-class scientists, advisors, and collaborators.

Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart.

Sabanto, Inc. is a company based in an undisclosed location with a mission to accelerate autonomy in agricultural machinery. The American company aims to solve the problems of labor scarcity in rural areas and the increasing capital expenses of modern ag machinery. Sabanto specializes in low-cost retrofits to existing agricultural machines, regardless of make or model, and the development of supporting software to maximize the utility of autonomous technology, increasing producer ROI. The company is creating simple, open, and cost-effective technologies that enable the future of agriculture. Sabanto's aftermarket autonomy system can increase productivity by making tractors autonomous.

Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.